Scott Cotler
  • Professor
  • FCO Division Director, Hepatology
  • Hepatology
Hepatitis B, Hepatitis C, Other causes of chronic liver disease, Cirrhosis, Liver Cancer
Board Certifications
  • Gastroenterology - Subspecialty Cert: AM Board of Internal Medicine
  • Internal Medicine - General Cert: AM Board of Internal Medicine
  • Transplant Hepatology - Subspecialty cert: AM Board of Internal Medicine

Presurgical transarterial chemoembolization does not increase biliary stricture incidence in orthotopic liver transplant patientsCasadaban,L.; Malespin,M.; Cheung,A.; McGuffey,R. A.; Boulay,B. R.; Halline,A. G.; Brown,R. D.; Cotler,S. J.; Jeon,H.; Bui,J. T.; Gaba,R. C.Transplantation proceedings 2014 ;46(5):1413-1419

Association of Genetic Variants With Rapid Fibrosis: Progression After Liver Transplantation for Hepatitis CLayden,J. E.; Tayo,B. O.; Cotler,S. J.; Clark,N. M.; Baraoidan,K.; Friedman,S. L.; Cooper,R. S.Transplantation 2014 ; ( ):

Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese American ChildrenMalespin,M.; Sleesman,B.; Lau,A.; Wong,S. S.; Cotler,S. J.Journal of clinical gastroenterology 2014 ; ( ):

Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-lifeGuedj,J.; Dahari,H.; Rong,L.; Sansone,N. D.; Nettles,R. E.; Cotler,S. J.; Layden,T. J.; Uprichard,S. L.; Perelson,A. S.Proceedings of the National Academy of Sciences of the United States of America 2013 ;110(10):3991-3996

Physical activity and metabolic syndrome in liver transplant recipientsKallwitz,E. R.; Loy,V.; Mettu,P.; Von Roenn,N.; Berkes,J.; Cotler,S. J.Liver Transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013 ; ( ):

Individualized treatment for patients with low HCV load (genotype 1): A viral kinetic approachDahari,H.; Cotler,S. J.Hepatology (Baltimore, Md.) 2013 ; ( ):

Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modelingDahari,H.; Cotler,S. J.; Layden,T. J.; Perelson,A. S.Journal of Hepatology 2013 ;58(4):840-842

Quantitative morphometric analysis of hepatocellular carcinoma: development of a programmed algorithm and preliminary applicationYap,F. Y.; Bui,J. T.; Knuttinen,M. G.; Walzer,N. M.; Cotler,S. J.; Owens,C. A.; Berkes,J. L.; Gaba,R. C.Diagnostic and interventional radiology (Ankara, Turkey) 2013 ;19(2):97-105

Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creationGaba,R. C.; Couture,P. M.; Bui,J. T.; Knuttinen,M. G.; Walzer,N. M.; Kallwitz,E. R.; Berkes,J. L.; Cotler,S. J.Journal of vascular and interventional radiology : JVIR 2013 ;24(3):411-20, 420.e1-4; quiz 421

Characterizing hepatitis B stigma in Chinese immigrantsCotler,S. J.; Cotler,S.; Xie,H.; Luc,B. J.; Layden,T. J.; Wong,S. S.Journal of viral hepatitis 2012 ;19(2):147-152

Barriers to treatment of hepatitis B in an urban Chinatown communityMalespin,M.; Wong,S.; Siqueira,F.; Luc,B.; Ravaee,B.; Vainder,C.; Cotler,S. J.Journal of clinical gastroenterology 2012 ;46(8):e66-70

Racial differences in fibrosis progression after HCV-related liver transplantationLayden,J. E.; Cotler,S.; Brown,K. A.; Lucey,M. R.; Te,H. S.; Eswaran,S.; Fimmel,C.; Layden,T. J.; Clark,N. M.Transplantation 2012 ;94(2):178-184

TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year periodGaba,R. C.; Omene,B. O.; Podczerwinski,E. S.; Knuttinen,M. G.; Cotler,S. J.; Kallwitz,E. R.; Berkes,J. L.; Walzer,N. M.; Bui,J. T.; Owens,C. A.Journal of vascular and interventional radiology : JVIR 2012 ;23(2):227-235

Characterizing hepatitis B stigma in Chinese immigrantsCotler,S. J.; Cotler,S.; Xie,H.; Luc,B. J.; Layden,T. J.; Wong,S. S.Journal of viral hepatitis 2012 ;19(2):147-152

Impact of donor and recipient race on survival after hepatitis C-related liver transplantationLayden,J. E.; Cotler,S. J.; Grim,S. A.; Fischer,M. J.; Lucey,M. R.; Clark,N. M.Transplantation 2012 ;93(4):444-449

Potential treatment options and future research to increase hepatitis C virus treatment response rateTencate,V.; Sainz,B.,Jr; Cotler,S. J.; Uprichard,S. L.Hepatic medicine : evidence and research 2010 ;2010(2):125-145

Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy.Bogetti,D.; Jarzembowski,T. M.; Sankary,H. N.; Manzelli,A.; Knight,P. S.; Chejfec,G.; Cotler,S.; Oberholzer,J.; Testa,G.; Benedetti,E.Transplantation proceedings 2005 ;37(1):404-406

Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury.Bogetti,D.; Sankary,H. N.; Jarzembowski,T. M.; Manzelli,A.; Knight,P. S.; Thielke,J.; Chejfec,G.; Cotler,S.; Oberholzer,J.; Testa,G.; Benedetti,E.Clinical transplantation 2005 ;19(4):507-511

Medical School
  • University of Chicago Pritzker School of Medicine
  • University of Chicago Medical Center, Internal Medicine: General
  • Rush-Presbyterian-St. Luke's Medical Center, Internal Medicine: Gastroenterology
  • University of Washington Medical Center, Internal Medicine: Hepatology